Direct advertisment created by G2, New Zealand for Arimidex, within the category: Pharmaceutical.
Can you pick which of your breast cancer patients will have a recurrence?
There’s no way to predict which of your patients will have recurring breast cancer. So it makes sense to treat all patients as women with some risk. Versus tamoxifen, Arimidex can improve every patient's chance of staying disease free.
RKS Design’s Scott Clear on Product Design’s Crucial Role in AdlandRead More
Clio Fashion & Beauty
Moving Image & Content Founder Quynh Mai On Bringing “Creative Firepower” To Digital StorytellingRead More
Agency of the Year X Country Winners Showcase Creativity Defined by CultureRead More
Pursue a Passion Project? We Want to Showcase It!Read More